Literature DB >> 34801596

Long noncoding RNA CBR3-AS1 mediates tumorigenesis and radiosensitivity of non-small cell lung cancer through redox and DNA repair by CBR3-AS1 /miR-409-3p/SOD1 axis.

Shilong Liu1, Ning Zhan2, Chunzi Gao3, Piao Xu2, Hong Wang4, Siyu Wang5, Shiqi Piao6, Suwei Jing6.   

Abstract

The long noncoding RNA CBR3-AS1 has important functions in various cancers. However, the biological functions of CBR3-AS1 in non-small cell lung cancer (NSCLC) remain unclear. This study aimed to investigate the roles and molecular mechanisms of CBR3-AS1 in NSCLC tumorigenesis and radiosensitivity. Here, we demonstrate CBR3-AS1 overexpression in NSCLC tissue compared with adjacent normal tissue. CBR3-AS1 downregulation reduced proliferation, invasion, and migration; inhibited cell cycle progression; and promoted apoptosis of NSCLC cells. CBR3-AS1 also promoted tumor growth in vivo. CBR3-AS1 may regulate the expression and functions of the miR-409-3p target gene SOD1. CBR3-AS1 expression was negatively correlated with radiosensitivity. CBR3-AS1 downregulation decreased post-irradiation SOD1 expression, increased γH2AX formation, raised levels of reactive oxygen species, and promoted apoptosis. Our results suggest that CBR3-AS1 functions as an oncogene through the CBR3-AS1/miR-409-3p/SOD1 pathway, and may represent a new therapeutic target, especially to regulate radiosensitivity in NSCLC.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Radioresistance; Reactive oxygen species; ceRNA; lncRNA; γH2AX

Mesh:

Substances:

Year:  2021        PMID: 34801596     DOI: 10.1016/j.canlet.2021.11.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

Review 1.  The Mechanism of Long Non-coding RNA in Cancer Radioresistance/Radiosensitivity: A Systematic Review.

Authors:  Wenhan Wu; Shijian Zhang; Jia He
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

Review 2.  LncRNAs and CircRNAs in cancer.

Authors:  Xin Yin; Huiran Lin; Lei Lin; Lei Miao; Jing He; Zhenjian Zhuo
Journal:  MedComm (2020)       Date:  2022-05-12

3.  Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors.

Authors:  Pavel V Ershov; Evgeniy O Yablokov; Leonid A Kaluzhskiy; Yuri V Mezentsev; Alexis S Ivanov
Journal:  Biology (Basel)       Date:  2022-04-13

4.  Long Noncoding RNA CBR3-AS1 Promotes Stem-like Properties and Oxaliplatin Resistance of Colorectal Cancer by Sponging miR-145-5p.

Authors:  Liangbao Xie; Guangfei Cui; Tao Li
Journal:  J Oncol       Date:  2022-04-12       Impact factor: 4.501

5.  The long non-coding RNA rhabdomyosarcoma 2-associated transcript exerts anti-tumor effects on lung adenocarcinoma via ubiquitination of SOX9.

Authors:  Yaofei Pei; Bing Zhou; Xiqiang Liu
Journal:  Ann Transl Med       Date:  2022-01

6.  Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β.

Authors:  Long-Jiang Chen; Lun Wu; Wei Wang; Lu-Lu Zhai; Feng Xiang; Wei-Bo Li; Zhi-Gang Tang
Journal:  Int J Oncol       Date:  2022-08-05       Impact factor: 5.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.